CRC patients with CD70+/POSTN+ CAFs had a significantly worse 5-year survival rate than other groups (33.1%; p = 0.00071; Figure 5), probably due to the frequent peritoneal and distant organ metastasis with incomplete resection status (Table 1). This evidence concerns the gene CD70 and colorectal carcinoma.